A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects
Clinical trial NCT05103878 · COMPLETED
Trial details
- NCT number
- NCT05103878
- Sponsor
- Bacainn Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-24
- Primary completion
- 2020-11-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.